Cargando…

Comparison of Intracoronary Epinephrine and Adenosine for No-Reflow in Normotensive Patients With Acute Coronary Syndrome (COAR Trial)

BACKGROUND: Intracoronary epinephrine has been effectively used in treating refractory no-reflow, but there is a dearth of data on its use as a first-line drug in normotensive patients in comparison to the widely used adenosine. METHODS: In this open-labeled randomized clinical trial, 201 patients w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khan, Kamran Ahmed, Qamar, Nadeem, Saghir, Tahir, Sial, Jawaid Akbar, Kumar, Dileep, Kumar, Rajesh, Qayyum, Danish, Yasin, Umamah, Jalbani, Javed, Karim, Musa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843359/ https://www.ncbi.nlm.nih.gov/pubmed/35000456 http://dx.doi.org/10.1161/CIRCINTERVENTIONS.121.011408

Ejemplares similares

Intracoronary epinephrine versus adenosine in the management of refractory no-reflow phenomenon: a single-center retrospective cohort study
por: Darwish, Ahmed, et al.
Publicado: (2022)

Predilation Ballooning in High Thrombus Laden STEMIs: An Independent Predictor of Slow Flow/No-Reflow in Patients Undergoing Emergent Percutaneous Coronary Revascularization
por: Kumar, Rajesh, et al.
Publicado: (2023)

Intracoronary epinephrine in the treatment of refractory no-reflow after primary percutaneous coronary intervention: a retrospective study
por: Aksu, Tolga, et al.
Publicado: (2015)

CHA(2) DS(2) -VASc score, a simple clinical tool for early prediction of no-reflow phenomenon in patients undergoing emergency percutaneous coronary revascularization
por: Shaikh, Abdul Hakeem, et al.
Publicado: (2022)

Comparison of angiographic results and clinical outcomes of no-reflow after stenting in left anterior descending (LAD) versus non-LAD culprit STEMI
por: Khan, Kamran Ahmed, et al.
Publicado: (2022)

Efficacy and safety of intracoronary epinephrine for the management of the no-reflow phenomenon following percutaneous coronary interventions: a systematic-review study
por: Jafari Afshar, Elmira, et al.
Publicado: (2023)

No-Reflow Phoenomenon by Intracoronary Thrombus in Acute Myocardial Infarction
por: Lim, Sang Yup
Publicado: (2016)

Management of no Reflow during Percutaneous Transcoronary Angioplasty with Catheter-Directed Intracoronary Thrombolysis: A Retrospective Observational Study
por: Singh, Rakendra, et al.
Publicado: (2022)

Meta-analysis of randomized controlled trials on the efficacy and safety of intracoronary administration of tirofiban for no-reflow phenomenon
por: Qin, Tao, et al.
Publicado: (2013)

Usefulness of Intracoronary Epinephrine in Severe Hypotension during Percutaneous Coronary Interventions
por: Choi, Jin Hee, et al.
Publicado: (2013)

Risk Factors Associated With Contrast-Induced Nephropathy after Primary Percutaneous Coronary Intervention
por: Kumar, Dileep, et al.
Publicado: (2020)

The Burden of Short-term Major Adverse Cardiac Events and its Determinants after Emergency Percutaneous Coronary Revascularization: A Prospective Follow-up Study
por: Kumar, Rajesh, et al.
Publicado: (2022)

Procedural determinants of fluoroscopy time in patients undergoing cardiac catheterization
por: Mujtaba, Syed Fayaz, et al.
Publicado: (2019)

Incidence, Predictors, and Outcomes of Acute and Sub-acute Stent Thrombosis after Emergency Percutaneous Coronary Revascularization with Drug-Eluting Stents: A Prospective Observational Study
por: Kumar, Rajesh, et al.
Publicado: (2022)

Intracoronary pressure gradient measurement in acute myocardial infarction patients with the no-reflow phenomenon during primary percutaneous coronary intervention
por: Gao, Ming-Dong, et al.
Publicado: (2020)

A meta-analysis of randomized controlled trials investigating tirofiban combined with conventional drugs by intracoronary administration for no-reflow prevention
por: Zeng, Qian, et al.
Publicado: (2020)

Autologous blood injection intracoronary artery for treating slow‐flow and no‐reflow in acute coronary syndrome related to primary pci
por: Truong Hoai, Lam, et al.
Publicado: (2022)

Immediate in-hospital outcomes after percutaneous revascularization of acute myocardial infarction complicated by cardiogenic shock
por: Solangi, Bashir Ahmed, et al.
Publicado: (2023)

Radial or femoral access in primary percutaneous coronary intervention (PCI): Does the choice matters?
por: Batra, Mahesh Kumar, et al.
Publicado: (2020)

Pakistan Following Foot Prints of Developed World in Structural Interventions: Experience of Transcatheter Aortic Valve Implantation Reported First Time
por: Ammar, Ali, et al.
Publicado: (2020)

Effect of intracoronary adenosine on ergonovine-induced vasoconstricted coronary arteries
por: Oh, Jun-Hyok, et al.
Publicado: (2020)

Index of Microcirculatory Resistance Measured during Intracoronary Adenosine-Induced Hyperemia
por: Santos-Pardo, Irene, et al.
Publicado: (2020)

Outcome at Six Months After Primary Percutaneous Coronary Interventions Performed at a Rural Satellite Center of Sindh Province of Pakistan
por: Mujtaba, Syed F, et al.
Publicado: (2020)

CoarSAS2hvec: Heterogeneous Information Network Embedding with Balanced Network Sampling
por: Zhan, Ling, et al.
Publicado: (2022)

Severe Anti-HMG-CoAR Necrotizing Autoimmune Myopathy Secondary to Statin Use
por: Pulipati, Priyanjali, et al.
Publicado: (2022)

Intracoronary Nicorandil and the Prevention of the No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction
por: Qi, Qi, et al.
Publicado: (2018)

Validity of the Stent Thrombosis Risk Score in Predicting Early Stent Thrombosis after Primary Percutaneous Coronary Intervention
por: Kumar, Rajesh, et al.
Publicado: (2020)

CoAR: Congestion-Aware Routing Protocol for Low Power and Lossy Networks for IoT Applications
por: Bhandari, Khadak Singh, et al.
Publicado: (2018)

Predictors of 6-month Mortality in Patients with Non-ST Elevation Acute Coronary Syndrome: A Study in Pakistani Population
por: Kumar, Dileep, et al.
Publicado: (2021)

One-year major adverse cardiovascular events among same-day discharged patients after primary percutaneous coronary intervention at a tertiary care cardiac centre in Karachi, Pakistan: a prospective observational study
por: Shah, Jehangir Ali, et al.
Publicado: (2023)

Acute hyperglycemia, a rabble-rouser or innocent bystander? A prospective analysis of clinical implications of acute hyperglycemia in STE-ACS patients
por: Kumar, Rajesh, et al.
Publicado: (2023)

Intracoronary fixed dose of nitroprusside via thrombus aspiration catheter for the prevention of the no-reflow phenomenon following primary percutaneous coronary intervention in acute myocardial infarction
por: ZHAO, YU-JUN, et al.
Publicado: (2013)

Effect of intracoronary agents on the no-reflow phenomenon during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a network meta-analysis
por: Niu, Xiaowei, et al.
Publicado: (2018)

Obesity paradox: a myth or reality, time to reveal the fact in a South Asian cohort presenting with STE-ACS undergoing primary percutaneous coronary intervention
por: Kumar, Rajesh, et al.
Publicado: (2023)

Tumour-specific HMG-CoAR is an independent predictor of recurrence free survival in epithelial ovarian cancer
por: Brennan, Donal J, et al.
Publicado: (2010)

Intracoronary adenosine-induced torsades de pointes during fractional flow reserve measurement
por: Degrauwe, Sophie, et al.
Publicado: (2019)

HMG-CoAR expression in male breast cancer: relationship with hormone receptors, Hippo transducers and survival outcomes
por: Di Benedetto, Anna, et al.
Publicado: (2016)

Characteristics of Adrenal Incidentalomas in a Large, Prospective Computed Tomography-Based Multicenter Study: The COAR Study in Korea
por: Ahn, Seong Hee, et al.
Publicado: (2018)

Intracoronary Versus Intravenous Adenosine-Induced Maximal Coronary Hyperemia for Fractional Flow Reserve Measurements
por: Khashaba, Ahmed, et al.
Publicado: (2014)

Cerebrovascular infarct associated with intracoronary adenosine: a possible rare fractional flow reserve complication
por: Keh, Yann Shan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uf5uh9b848baseik4t3ngkdan7